Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | RPRX |
---|---|---|
09:32 ET | 28786 | 28.17 |
09:34 ET | 19548 | 28.625 |
09:36 ET | 13510 | 28.57 |
09:38 ET | 9995 | 28.705 |
09:39 ET | 4400 | 28.81 |
09:41 ET | 3928 | 28.7 |
09:43 ET | 21314 | 28.42 |
09:45 ET | 6286 | 28.3 |
09:48 ET | 13609 | 28.18 |
09:50 ET | 8366 | 28.1464 |
09:52 ET | 15999 | 28.385 |
09:54 ET | 4680 | 28.269 |
09:56 ET | 5051 | 28.33 |
09:57 ET | 6058 | 28.3 |
09:59 ET | 11667 | 28.385 |
10:01 ET | 13109 | 28.42 |
10:03 ET | 9700 | 28.34 |
10:06 ET | 7909 | 28.3 |
10:08 ET | 13023 | 28.379 |
10:10 ET | 6427 | 28.405 |
10:12 ET | 5741 | 28.46 |
10:14 ET | 52762 | 28.58 |
10:15 ET | 14262 | 28.59 |
10:17 ET | 6264 | 28.545 |
10:19 ET | 16205 | 28.61 |
10:21 ET | 7149 | 28.58 |
10:24 ET | 8267 | 28.54 |
10:26 ET | 5477 | 28.53 |
10:28 ET | 5268 | 28.52 |
10:30 ET | 6129 | 28.52 |
10:32 ET | 3097 | 28.47 |
10:33 ET | 9237 | 28.45 |
10:35 ET | 3758 | 28.49 |
10:37 ET | 6964 | 28.41 |
10:39 ET | 5077 | 28.415 |
10:42 ET | 91681 | 28.4092 |
10:44 ET | 8072 | 28.365 |
10:46 ET | 3106 | 28.37 |
10:48 ET | 3066 | 28.38 |
10:50 ET | 14317 | 28.37 |
10:51 ET | 6285 | 28.36 |
10:53 ET | 9364 | 28.32 |
10:55 ET | 17369 | 28.28 |
10:57 ET | 8605 | 28.31 |
11:00 ET | 6700 | 28.35 |
11:02 ET | 3650 | 28.36 |
11:04 ET | 3405 | 28.345 |
11:06 ET | 945 | 28.355 |
11:08 ET | 7178 | 28.36 |
11:09 ET | 4473 | 28.405 |
11:11 ET | 15840 | 28.39 |
11:13 ET | 3460 | 28.4 |
11:15 ET | 4211 | 28.375 |
11:18 ET | 19490 | 28.405 |
11:20 ET | 43437 | 28.475 |
11:22 ET | 41840 | 28.55 |
11:24 ET | 9829 | 28.48 |
11:26 ET | 20337 | 28.49 |
11:27 ET | 5113 | 28.54 |
11:29 ET | 3483 | 28.58 |
11:31 ET | 4121 | 28.54 |
11:33 ET | 8330 | 28.5 |
11:36 ET | 3411 | 28.47 |
11:38 ET | 2890 | 28.4 |
11:40 ET | 4400 | 28.39 |
11:42 ET | 6320 | 28.39 |
11:44 ET | 3782 | 28.415 |
11:45 ET | 2528 | 28.43 |
11:47 ET | 6728 | 28.42 |
11:49 ET | 2572 | 28.405 |
11:51 ET | 31521 | 28.36 |
11:54 ET | 6552 | 28.36 |
11:56 ET | 7977 | 28.325 |
11:58 ET | 2561 | 28.325 |
12:00 ET | 14279 | 28.31 |
12:02 ET | 2660 | 28.29 |
12:03 ET | 5527 | 28.285 |
12:05 ET | 12953 | 28.22 |
12:07 ET | 5323 | 28.205 |
12:09 ET | 5742 | 28.185 |
12:12 ET | 3960 | 28.155 |
12:14 ET | 6762 | 28.14 |
12:16 ET | 6789 | 28.16 |
12:18 ET | 6835 | 28.13 |
12:20 ET | 6538 | 28.21 |
12:21 ET | 9099 | 28.2 |
12:23 ET | 5449 | 28.21 |
12:25 ET | 11772 | 28.24 |
12:27 ET | 13811 | 28.28 |
12:30 ET | 2143 | 28.235 |
12:32 ET | 1103 | 28.22 |
12:34 ET | 1542 | 28.2 |
12:36 ET | 7147 | 28.2 |
12:38 ET | 6960 | 28.23 |
12:39 ET | 1856 | 28.22 |
12:41 ET | 1691 | 28.2 |
12:43 ET | 7174 | 28.205 |
12:45 ET | 3789 | 28.205 |
12:48 ET | 5106 | 28.195 |
12:50 ET | 15595 | 28.23 |
12:52 ET | 3984 | 28.26 |
12:54 ET | 3854 | 28.25 |
12:56 ET | 1730 | 28.24 |
12:57 ET | 1237 | 28.23 |
12:59 ET | 8786 | 28.25 |
01:01 ET | 3121 | 28.27 |
01:03 ET | 2541 | 28.31 |
01:06 ET | 4716 | 28.28 |
01:08 ET | 4289 | 28.34 |
01:10 ET | 2626 | 28.345 |
01:12 ET | 4425 | 28.36 |
01:14 ET | 3405 | 28.32 |
01:15 ET | 2365 | 28.29 |
01:17 ET | 5372 | 28.305 |
01:19 ET | 18555 | 28.34 |
01:21 ET | 5100 | 28.345 |
01:24 ET | 1429 | 28.3 |
01:26 ET | 4957 | 28.315 |
01:28 ET | 2465 | 28.31 |
01:30 ET | 5373 | 28.305 |
01:32 ET | 4185 | 28.3 |
01:33 ET | 5632 | 28.29 |
01:35 ET | 2390 | 28.285 |
01:37 ET | 2077 | 28.265 |
01:39 ET | 4282 | 28.25 |
01:42 ET | 5679 | 28.24 |
01:44 ET | 1914 | 28.255 |
01:46 ET | 500 | 28.26 |
01:48 ET | 2796 | 28.265 |
01:50 ET | 11608 | 28.275 |
01:51 ET | 6317 | 28.23 |
01:53 ET | 5182 | 28.2089 |
01:55 ET | 1386 | 28.19 |
01:57 ET | 2910 | 28.16 |
02:00 ET | 3422 | 28.17 |
02:02 ET | 1241 | 28.155 |
02:04 ET | 5139 | 28.185 |
02:06 ET | 1672 | 28.19 |
02:08 ET | 12073 | 28.15 |
02:09 ET | 3211 | 28.165 |
02:11 ET | 1100 | 28.15 |
02:13 ET | 3618 | 28.135 |
02:15 ET | 1780 | 28.145 |
02:18 ET | 3581 | 28.145 |
02:20 ET | 1546 | 28.145 |
02:22 ET | 3026 | 28.1599 |
02:24 ET | 2799 | 28.175 |
02:26 ET | 789 | 28.185 |
02:27 ET | 1197 | 28.185 |
02:29 ET | 10431 | 28.17 |
02:31 ET | 2011 | 28.155 |
02:33 ET | 5339 | 28.16 |
02:36 ET | 1281 | 28.165 |
02:38 ET | 2537 | 28.175 |
02:40 ET | 2299 | 28.19 |
02:42 ET | 6050 | 28.21 |
02:44 ET | 6460 | 28.195 |
02:45 ET | 2828 | 28.18 |
02:47 ET | 5690 | 28.175 |
02:49 ET | 4825 | 28.135 |
02:51 ET | 7550 | 28.11 |
02:54 ET | 8270 | 28.175 |
02:56 ET | 4808 | 28.18 |
02:58 ET | 11362 | 28.19 |
03:00 ET | 8321 | 28.18 |
03:02 ET | 12343 | 28.15 |
03:03 ET | 5068 | 28.155 |
03:05 ET | 5333 | 28.14 |
03:07 ET | 8698 | 28.13 |
03:09 ET | 6869 | 28.115 |
03:12 ET | 8798 | 28.1 |
03:14 ET | 9190 | 28.135 |
03:16 ET | 6950 | 28.105 |
03:18 ET | 16642 | 28.115 |
03:20 ET | 11007 | 28.105 |
03:21 ET | 7060 | 28.0725 |
03:23 ET | 8622 | 28.07 |
03:25 ET | 13547 | 28.065 |
03:27 ET | 8393 | 28.08 |
03:30 ET | 11734 | 28.05 |
03:32 ET | 18790 | 28.09 |
03:34 ET | 24806 | 28.1 |
03:36 ET | 8686 | 28.055 |
03:38 ET | 16596 | 28.04 |
03:39 ET | 11967 | 28.035 |
03:41 ET | 22061 | 28.01 |
03:43 ET | 35184 | 27.985 |
03:45 ET | 19316 | 27.955 |
03:48 ET | 25751 | 27.92 |
03:50 ET | 19015 | 27.91 |
03:52 ET | 38266 | 27.91 |
03:54 ET | 64471 | 27.93 |
03:56 ET | 66517 | 27.96 |
03:57 ET | 59423 | 27.985 |
03:59 ET | 513236 | 27.97 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Royalty Pharma PLC | 16.7B | 11.0x | +1.83% |
Amneal Pharmaceuticals Inc | 2.0B | -11.5x | --- |
Catalent Inc | 10.2B | -7.8x | --- |
Jazz Pharmaceuticals PLC | 7.0B | 23.3x | -3.53% |
Mallinckrodt PLC | 1.6M | 0.0x | --- |
Prestige Consumer Healthcare Inc | 3.5B | -42.8x | --- |
Royalty Pharma plc is a buyer of biopharmaceutical royalties and a funder of innovation across the biopharmaceutical industry. The Company collaborates with innovators from academic institutions, research hospitals and non-profits through small and mid-cap biotechnology companies to global pharmaceutical companies. Its portfolio consists of royalties on over 35 commercial products, including Vertex’s Trikafta, GSK’s Trelegy, Roche’s Evrysdi, Johnson & Johnson’s Tremfya, Biogen’s Tysabri and Spinraza, AbbVie and Johnson & Johnson’s Imbruvica, Astellas and Pfizer’s Xtandi, Novartis’ Promacta, Pfizer’s Nurtec ODT and Gilead’s Trodelvy, and 14 development-stage product candidates. Its development-stage product candidates include Aficamten, Ampreloxetine, BCX10013, MK-8189, Ecopipam, Olpasiran, Pelabresib, KarXT, Pelacarsen, Seltorexant, Trontinemab, TEV-'749, Tulmimetostat and Vanzacaftor. Its subsidiaries include Royalty Pharma Holdings Ltd., Royalty Pharma Investments and others.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $16.7B |
---|---|
Revenue (TTM) | $2.4B |
Shares Outstanding | 597.4M |
Dividend Yield | 3.00% |
Annual Dividend Rate | 0.8400 USD |
Ex-Dividend Date | 05-16-24 |
Pay Date | 06-14-24 |
Beta | 0.47 |
EPS | $2.54 |
Book Value | $14.61 |
P/E Ratio | 11.0x |
Price/Sales (TTM) | 7.1 |
Price/Cash Flow (TTM) | 9.8x |
Operating Margin | 63.37% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.